Reduction in sepsis mortality is directly dependent on early identification and rapid initiation of appropriate antimicrobial therapy. Fast and accurate diagnosis may also shorten the length of a hospital stay and potentially help reduce the emergence of multidrug-resistant bacteria.
bioMérieux Joins the Scientific World in Celebrating the Legacy of Stuart Levy, MD
Antimicrobial resistance is a major public health issue across the globe. On September 4, 2019, we lost a partner in that mission. Stuart Levy, MD, one of the earliest and loudest voices warning of the dangers of antibiotic overuse in both humans and animals, passed away after a prolonged illness.
“On the Front Lines” Webinar Series, September 12—New Technology and Workflow Optimization in the Microbiology Lab: Working Together to Improve Patient Care
During our September 12, 2019 webinar, titled, “New Technology and Workflow Optimization in the Microbiology Lab: Working Together to Improve Patient Care,” Dr. Allison McMullen, Ph.D., D(ABMM), will share how microbiology is meeting today’s clinical challenges in the context of Antimicrobial Stewardship Programs (ASPs).
FDA Approves a New Antibiotic to Treat Pneumonia
Lefamulin’s mechanism of action has a low inclination for developing resistance. The drug is a member of the pleuromutilin antibiotic class, and it has low propensity for cross resistance with a variety of antibiotic classes such as macrolide and tetracycline.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...